Comparing the Efficacy of Different AntibioticRegimens in Treating Community-Acquired Pneumonia: A Prospective Observational Study

Community-acquired pneumonia (CAP) continues to represent a significant cause of morbidity and mortality worldwide. Antibiotic therapy is fundamental to its management, with various regimens incorporating beta-lactams, macrolides, and fluoroquinolones frequently utilized. This prospective observational study aimed to evaluate the efficacy of three distinct antibiotic regimens in the treatment of CAP. A total of 96 patients diagnosed with CAP were enrolled and divided equally into three groups: beta-lactam, macrolide, and fluoroquinolone. The study was conducted over six months and assessed clinical outcomes, including fever resolution, length of hospital stay, and adverse effects, in conjunction with patient demographics. The findings suggest that while all regimens demonstrated effectiveness, notable differences in patient outcomes were observed, underscoring the necessity for tailored treatment strategies.